JP2023518208A5 - - Google Patents

Info

Publication number
JP2023518208A5
JP2023518208A5 JP2022555078A JP2022555078A JP2023518208A5 JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5 JP 2022555078 A JP2022555078 A JP 2022555078A JP 2022555078 A JP2022555078 A JP 2022555078A JP 2023518208 A5 JP2023518208 A5 JP 2023518208A5
Authority
JP
Japan
Prior art keywords
alkyl
therapeutic agent
amino
agent according
haloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022555078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518208A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/080540 external-priority patent/WO2021180219A1/zh
Publication of JP2023518208A publication Critical patent/JP2023518208A/ja
Publication of JP2023518208A5 publication Critical patent/JP2023518208A5/ja
Pending legal-status Critical Current

Links

JP2022555078A 2020-03-13 2021-03-12 Pi4k阻害物質の抗コロナウイルス効果および応用 Pending JP2023518208A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202010177429.3 2020-03-13
CN202010177429 2020-03-13
PCT/CN2021/080540 WO2021180219A1 (zh) 2020-03-13 2021-03-12 Pi4k抑制剂的抗冠状病毒效果以及应用

Publications (2)

Publication Number Publication Date
JP2023518208A JP2023518208A (ja) 2023-04-28
JP2023518208A5 true JP2023518208A5 (https=) 2024-03-21

Family

ID=77672132

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022555078A Pending JP2023518208A (ja) 2020-03-13 2021-03-12 Pi4k阻害物質の抗コロナウイルス効果および応用

Country Status (10)

Country Link
US (1) US20250152599A1 (https=)
EP (1) EP4119164A4 (https=)
JP (1) JP2023518208A (https=)
KR (1) KR20230022150A (https=)
CN (1) CN115884789B (https=)
AU (1) AU2021236089B2 (https=)
CA (1) CA3170611A1 (https=)
MX (1) MX2022011138A (https=)
WO (1) WO2021180219A1 (https=)
ZA (1) ZA202210111B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024537837A (ja) * 2021-09-30 2024-10-16 ヌオ-ベータ・ファーマシューティカル・テクノロジー(シャンハイ)カンパニー・リミテッド ハロゲン化フェニルアルシンオキシド化合物およびその用途
CN117695281B (zh) * 2023-12-26 2024-06-21 广州医科大学 四氢喹啉酮-酰胺-噻唑类化合物的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923895A (en) * 1988-10-24 1990-05-08 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of treatment of human immunodeficiency virus
US5532154A (en) * 1994-03-21 1996-07-02 Research Development Foundation Mutated alpha virus
WO1998051297A1 (en) * 1997-05-14 1998-11-19 The University Of New Mexico Inhibition of cell surface protein disulfide isomerase
AU2149600A (en) * 1998-11-12 2000-05-29 Musc Foundation For Research Development Methods and compositions for treating common cold symptoms
WO2005060520A2 (en) * 2003-11-25 2005-07-07 Dana-Farber Cancer Institute, Inc. ANTIBODIES AGAINST SARS-CoV AND METHODS OF USE THEREOF
US20060089324A1 (en) * 2004-10-22 2006-04-27 Sailen Barik RNAi modulation of RSV, PIV and other respiratory viruses and uses thereof
WO2009121219A1 (zh) * 2008-04-02 2009-10-08 Ding Xinkan 砷化物在制备抗病毒药物中的应用
WO2012174312A2 (en) * 2011-06-15 2012-12-20 Glaxosmithkline Llc Benzimidazole derivatives as antiviral agents
WO2015135652A1 (en) * 2014-03-12 2015-09-17 Technische Universität München Antagonists of acid lipase for preventing virus infection
WO2016172952A1 (zh) * 2015-04-30 2016-11-03 江苏挪贝肽医药科技有限公司 PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用
WO2017147526A1 (en) * 2016-02-26 2017-08-31 The Board Of Trustees Of The Leland Stanford Junior University Pi-kinase inhibitors with anti-infective activity
CN108721622B (zh) * 2017-04-14 2022-10-25 中国科学院上海高等研究院 抑制肝纤维化的试剂及应用
BR112022019864A2 (pt) * 2020-03-31 2022-11-16 Nuo Beta Pharmaceutical Tech Shanghai Co Ltd Composto de oxofenilarsina deuterada e uso do mesmo

Similar Documents

Publication Publication Date Title
CN107693797B (zh) 肽寡核苷酸缀合物
JP6294889B2 (ja) ウイルス疾患の処置におけるmek阻害物質
JP2023518208A5 (https=)
TW201542538A (zh) 抗病毒化合物、醫藥組合物及其使用方法
JP2010501584A5 (https=)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
JP2014526456A (ja) 過剰増殖性疾患、好ましくはp53機能欠損の治療に用いるためのCIP2Aサイレンシング剤を含む併用薬剤
JP2024530956A5 (https=)
JP2014505107A5 (https=)
TW201907009A (zh) 用於治療b型肝炎之治療組成物及方法
BR112020018601A2 (pt) Regime de dosagem de modulador de montagem de capsídeo
TW201625573A (zh) 色烯酮(chromenone)抗病毒化合物、醫藥組合物及其使用方法
CN115884789A (zh) Pi4k抑制剂的抗冠状病毒效果以及应用
TW201912153A (zh) 用於治療b型肝炎的化合物、醫藥組合物及方法
CA2738070C (en) Novel compounds for the treatment or alleviation of edema, and methods for their use
JP2022553856A (ja) ウイルス分子レベルを低減する方法
US10358447B2 (en) Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same
JP2024504632A (ja) 非アルコール性脂肪肝疾患および関連する疾患または障害を処置または改善するための化合物、組成物および方法
JP7590351B2 (ja) Prmt5阻害剤を使用した癌の治療法
JP2022550072A5 (https=)
AU2019341976A1 (en) Cancer combination therapy using quinoline carboxamide derivative
CN114057816B (zh) 富含腺嘌呤硫代磷酸酯化寡核苷酸及其抗肝炎病毒的应用
WO2023070058A1 (en) Treatment of viruses with antiviral nucleosides
US20230364074A1 (en) Compounds and Compositions for Disrupting Programmed Ribosomal Frameshifting
JP2015527316A5 (https=)